7.600
+0,00%
2026-07-03
Fundamental Analysis
44 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +48.7% | +141.4% | 2 / 3 | -1.5% | -0.11 pp | +0.46 pp | +8.5% | 1.80 | 7.66 | 201 | −1,5% | 2,8 | +48,7% | 7.66 | 13.59 | −43,7% |
| Pts | 8 | 12 | 8 | 0 | 4 | 8 | 0 | -4 | 12 | |||||||
Valuation annotation:Price: 7.600 (close price on 2026-07-03)EPS (TTM): 992,5
Financial charts
1.Revenue & growth
VND bn201Q2/26
1.Revenue & growth
VND bn201Q2/26
2.Profit & growth
VND bn2,75Q2/26
3.Profit mix (Penman)
VND bn15,1Q2/26
4.Margins & cost structure
%8.8%Q2/26
5.Returns & cash cycle
% · days3.7%Q2/26
6.Earnings quality & cash
VND bn-42,1Q2/26
7.Asset structure
VND bn472Q2/26
8.Funding & debt health
VND bn · times472Q2/26
9.Revenue backlog
VND bn0,23Q2/26
10.Valuation
times · %7,7×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %229Q2/26
Adjusted EPS growth, latest quarter
48.7%
Average adjusted EPS growth, 3 quarters
7.1%
averaged over 2 quarter(s)
Quarters at 25%+ growth
2/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26